Skip to main content

Hyperlipoproteinemia Type IIa (Elevated LDL) News

Related terms: Fredrickson Type IIa Hyperlipoproteinemia, Hyperlipoproteinemia, Fredrickson Type IIa

When Statins Aren't Enough, This Drug May Help Lower 'Bad' Cholesterol

THURSDAY, May 8, 2025 — A new drug combo lowers "bad" LDL cholesterol for people whose levels remain high even after taking statins. The new pill pairs a new drug called obicetrapib with an existing o...

Low 'Bad' Cholesterol Might Protect Against Dementia, Alzheimer's

WEDNESDAY, April 2, 2025 – Lower levels of “bad” LDL cholesterol could mean a lower risk of dementia and Alzheimer’s disease, a new study says. People with low-density lipoprotein (LDL) cholesterol l...

Combination Lipid-Lowering Therapy Linked to Greater Drop in LDL-C

FRIDAY, March 28, 2025 – Combination lipid-lowering therapy (LLT) is associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C) compared with statin monotherapy, according to...

Olpasiran Leads to Significant Reduction in Oxidized Phospholipids

FRIDAY, Feb. 21, 2025 – Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) production, leads to a significant and sustained reduction in oxidized phospholipids (OxPL) on...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

atorvastatin, Lipitor, simvastatin, Crestor, pravastatin, cholestyramine, rosuvastatin